The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Uveges George since 2007.
The trader's CIK number is 1124927.
At the time of the last reporting, Uveges George was the Director of Harvard Bioscience Inc. (stock ticker symbol HBIO).
Also see all insider trading activities at Harvard Bioscience Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2008 | MFLU.OB | 10,000 | $5,550 | 0 | $0 | 0 | $0 |
2007 | MFLU.OB | 20,000 | $22,529 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2018 | HBIO | 0 | $0 | 57,304 | $263,503 | 6,586 | $22,458 |
2017 | HBIO | 0 | $0 | 0 | $0 | 67,478 | $167,143 |
2016 | HBIO | 0 | $0 | 0 | $0 | 6,589 | $19,832 |
2015 | HBIO | 3,000 | $9,960 | 0 | $0 | 32,928 | $99,771 |
2009 | HBIO | 2,500 | $9,250 | 0 | $0 | 0 | $0 |
2008 | HBIO | 2,500 | $4,890 | 0 | $0 | 0 | $0 |
2007 | HBIO | 5,000 | $20,722 | 0 | $0 | 0 | $0 |
2. Harvard Bioscience Inc (HBIO)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2008-11-26 | MFLU.OB | Buy | 10,000 | .56 | 5,550 |
2007-11-19 | MFIC.OB | Buy | 9,000 | 1.11 | 9,990 |
2007-11-20 | MFIC.OB | Buy | 11,000 | 1.14 | 12,539 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2018-03-12 | HBIO | Option Ex | 6,586 | 3.41 | 22,458 |
2018-03-14 | HBIO | Sale | 22,250 | 4.58 | 101,905 |
2018-03-07 | HBIO | Sale | 35,054 | 4.61 | 161,598 |
2017-09-07 | HBIO | Option Ex | 67,478 | 2.48 | 167,143 |
2016-05-17 | HBIO | Option Ex | 6,589 | 3.01 | 19,832 |
2015-12-03 | HBIO | Buy | 3,000 | 3.32 | 9,960 |
2015-12-02 | HBIO | Option Ex | 32,928 | 3.03 | 99,771 |
2009-09-15 | HBIO | Buy | 2,500 | 3.70 | 9,250 |
2008-11-26 | HBIO | Buy | 2,500 | 1.96 | 4,890 |
2007-12-11 | HBIO | Buy | 4,000 | 4.13 | 16,512 |
2007-12-12 | HBIO | Buy | 1,000 | 4.21 | 4,210 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Uveges George (Director of Harvard Bioscience Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.